Latest Commercialization News

Page 298 of 380
BrainChip Holdings Ltd’s 2025 AGM reveals a strengthened product roadmap, breakthrough Edge AI technology advances, and a surge in commercial partnerships, positioning the company for accelerated growth.
Sophie Babbage
Sophie Babbage
6 May 2025
FOS Capital has acquired Melbourne-based lighting design consultancy Glowing Structures for $700,000, aiming to deepen its footprint in the lighting services sector. The deal includes cash and shares, with Glowing Structures’ founder staying on as Managing Director.
Victor Sage
Victor Sage
6 May 2025
SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.
Victor Sage
Victor Sage
6 May 2025
HyTerra Limited has confirmed hydrogen concentrations up to 96.1% in its Sue Duroche 3 well in Kansas, reinforcing the potential of its natural hydrogen exploration program. Elevated helium levels were also detected, with further testing planned to assess commercial viability.
Maxwell Dee
Maxwell Dee
6 May 2025
Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.
Ada Torres
Ada Torres
6 May 2025
Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.
Maxwell Dee
Maxwell Dee
6 May 2025
Kingsland Minerals has appointed GR Engineering Services to lead a scoping study for its Leliyn Graphite Project, aiming to unlock the economic potential of one of Australia’s largest graphite resources. The study, supported by new project management expertise and existing off-take agreements, is set to complete by year-end.
Maxwell Dee
Maxwell Dee
6 May 2025
Biome Australia is expanding its health portfolio with Activated Therapeutics, a new practitioner-only brand launching four evidence-based natural medicine products in Q4 2025.
Ada Torres
Ada Torres
6 May 2025
Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.
Ada Torres
Ada Torres
6 May 2025
Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.
Sophie Babbage
Sophie Babbage
6 May 2025
Blue Star Helium has successfully drilled the Jackson 2 well to total depth at its Galactica project in Colorado, confirming strong natural gas flow and advancing the project toward commercial production.
Maxwell Dee
Maxwell Dee
6 May 2025
Altech Batteries has launched an operational pilot plant in Germany producing its proprietary Silumina Anodes, promising a 50% increase in lithium-ion battery capacity with improved longevity.
Victor Sage
Victor Sage
6 May 2025